BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borkham-kamphorst E, Herrmann J, Stoll D, Treptau J, Gressner AM, Weiskirchen R. Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest 2004;84:766-77. [DOI: 10.1038/labinvest.3700094] [Cited by in Crossref: 106] [Cited by in F6Publishing: 113] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Medina-Flores F, Hurtado-Alvarado G, Deli MA, Gómez-González B. The Active Role of Pericytes During Neuroinflammation in the Adult Brain. Cell Mol Neurobiol 2022. [PMID: 35195811 DOI: 10.1007/s10571-022-01208-5] [Reference Citation Analysis]
2 Zhou L, Li Y, Liang Q, Liu J, Liu Y. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: A review. J Drug Target 2022;:1-22. [PMID: 35179094 DOI: 10.1080/1061186X.2022.2044485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu T, Chen S, Xie X, Liu H, Wang Y, Qi S, Shi L, Zhou X, Zhang J, Wang S, Wang Y, Chen S, Dou S, Jiang X, Cui R, Jiang H. Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis. J Cell Mol Med 2021. [PMID: 34750987 DOI: 10.1111/jcmm.17033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ezhilararasan D, Lakshmi T, Raut B, S VK. Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver. Journal of Nanomaterials 2021;2021:1-9. [DOI: 10.1155/2021/4674046] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Yamaguchi M, Dohi N, Ooka A, Saito SY, Ishikawa T. Caffeine-induced inversion of prostaglandin E2 effects on hepatic stellate cell activation. Biomed Pharmacother 2021;142:111989. [PMID: 34388524 DOI: 10.1016/j.biopha.2021.111989] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang J, You J, Gong D, Xu Y, Yang B, Jiang C. PDGF-BB induces conversion, proliferation, migration, and collagen synthesis of oral mucosal fibroblasts through PDGFR-β/PI3K/ AKT signaling pathway. Cancer Biomark 2021;30:407-15. [PMID: 33492283 DOI: 10.3233/CBM-201681] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, Kirton KJ, Shah AP, Dang H. Hepatic Stellate Cells and Hepatocarcinogenesis. Front Cell Dev Biol 2020;8:709. [PMID: 32850829 DOI: 10.3389/fcell.2020.00709] [Cited by in Crossref: 17] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
8 Li HG, You PT, Xia Y, Cai Y, Tu YJ, Wang MH, Song WC, Quan TM, Ren HY, Liu YW, Dan HX, Xu SQ. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl4-induced Liver Fibrosis Rats. Curr Med Sci 2020;40:539-47. [PMID: 32681257 DOI: 10.1007/s11596-020-2211-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Sundaram B, Behnke K, Belancic A, Al-Salihi MA, Thabet Y, Polz R, Pellegrino R, Zhuang Y, Shinde PV, Xu HC, Vasilevska J, Longerich T, Herebian D, Mayatepek E, Bock HH, May P, Kordes C, Aghaeepour N, Mak TW, Keitel V, Häussinger D, Scheller J, Pandyra AA, Lang KS, Lang PA. iRhom2 inhibits bile duct obstruction-induced liver fibrosis. Sci Signal 2019;12:eaax1194. [PMID: 31662486 DOI: 10.1126/scisignal.aax1194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Li Q, Li H, Lv Y, Zhang Q, Zhang X, Li S, Zheng X, Wang Y, Hao Z. Hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II. Lab Invest 2020;100:466-82. [PMID: 31641222 DOI: 10.1038/s41374-019-0314-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Chen C, Li X, Wang L. Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways. Dig Liver Dis 2020;52:324-30. [PMID: 31542221 DOI: 10.1016/j.dld.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
12 Yin F, Wang WY, Jiang WH. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms. World J Stem Cells 2019; 11(8): 548-564 [PMID: 31523373 DOI: 10.4252/wjsc.v11.i8.548] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
13 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
14 Peng Y, Li L, Zhang X, Xie M, Yang C, Tu S, Shen H, Hu G, Tao L, Yang H. Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways. Exp Ther Med 2019;18:41-8. [PMID: 31258636 DOI: 10.3892/etm.2019.7548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Liu M, Hu Y, Yuan Y, Tian Z, Zhang C. γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells. Front Immunol 2019;10:477. [PMID: 30930903 DOI: 10.3389/fimmu.2019.00477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
16 Shah R, Reyes-Gordillo K, Rojkind M. Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain. Expert Opin Biol Ther 2018;18:177-84. [PMID: 30063851 DOI: 10.1080/14712598.2018.1478961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
17 Gracia-sancho J, Marrone G, Fernández-iglesias A. Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol 2019;16:221-34. [DOI: 10.1038/s41575-018-0097-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 18.5] [Reference Citation Analysis]
18 O’Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer. World J Gastroenterol 2018; 24(39): 4436-4447 [PMID: 30357021 DOI: 10.3748/wjg.v24.i39.4436] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 62] [Article Influence: 18.3] [Reference Citation Analysis]
19 Ma Z, Liu X, Dong H, Xia D, Wang L, Chen Y, Xiong Y. Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice. Parasitol Res 2018;117:2831-9. [PMID: 29946766 DOI: 10.1007/s00436-018-5972-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Wahid B, Ali A, Rafique S, Saleem K, Waqar M, Wasim M, Idrees M. Role of altered immune cells in liver diseases: a review. Gastroenterología y Hepatología (English Edition) 2018;41:377-88. [DOI: 10.1016/j.gastre.2018.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Wahid B, Ali A, Rafique S, Saleem K, Waqar M, Wasim M, Idrees M. Role of altered immune cells in liver diseases: a review. Gastroenterol Hepatol. 2018;41:377-388. [PMID: 29605453 DOI: 10.1016/j.gastrohep.2018.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Zhang LT, Peng XB, Fang XQ, Li JF, Chen H, Mao XR. Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro. Int J Mol Med. 2018;41:2545-2552. [PMID: 29484382 DOI: 10.3892/ijmm.2018.3500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
23 Jia Z, Gong Y, Pi Y, Liu X, Gao L, Kang L, Wang J, Yang F, Tang J, Lu W, Li Q, Zhang W, Yan Z, Yu L. pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis. Mol Pharm 2018;15:53-62. [PMID: 29148802 DOI: 10.1021/acs.molpharmaceut.7b00709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
24 Klinkhammer BM, Floege J, Boor P. PDGF in organ fibrosis. Mol Aspects Med 2018;62:44-62. [PMID: 29155002 DOI: 10.1016/j.mam.2017.11.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 82] [Article Influence: 12.8] [Reference Citation Analysis]
25 Cannito S, Novo E, Parola M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev 2017;121:57-84. [PMID: 28578015 DOI: 10.1016/j.addr.2017.05.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
26 Liu H, Chen Z, Jin W, Barve A, Wan YY, Cheng K. Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells. Liver Res 2017;1:70-9. [PMID: 28966795 DOI: 10.1016/j.livres.2017.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
27 Qin DM, Zhang Y, Li L. Progress in research of Chinese herbal medicines with anti-hepatic fibrosis activity. Shijie Huaren Xiaohua Zazhi 2017; 25(11): 958-965 [DOI: 10.11569/wcjd.v25.i11.958] [Reference Citation Analysis]
28 Lambrecht J, Jan Poortmans P, Verhulst S, Reynaert H, Mannaerts I, van Grunsven LA. Circulating ECV-Associated MiRNA s as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis. Front Pharmacol. 2017;8:56. [PMID: 28232800 DOI: 10.3389/fphar.2017.00056] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
29 Chen Q, Chen L, Kong D, Shao J, Wu L, Zheng S. Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-βR/ERK signaling pathway. Int Immunopharmacol. 2016;34:250-258. [PMID: 27038258 DOI: 10.1016/j.intimp.2016.03.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
30 Huang Q, Wei L, Liang C, Nie J, Lu S, Lu C, Tan S, Lv S, Zhuo L, Lu Z, Lin X. Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis. Biomed Pharmacother 2016;82:669-76. [PMID: 27470410 DOI: 10.1016/j.biopha.2016.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
31 Weiskirchen R. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Front Pharmacol. 2015;6:303. [PMID: 26779021 DOI: 10.3389/fphar.2015.00303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
32 Tag CG, Weiskirchen S, Hittatiya K, Tacke F, Tolba RH, Weiskirchen R. Induction of experimental obstructive cholestasis in mice. Lab Anim. 2015;49:70-80. [PMID: 25835740 DOI: 10.1177/0023677214567748] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
33 Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53-61. [PMID: 26547628 DOI: 10.1016/j.cytogfr.2015.10.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 83] [Article Influence: 10.1] [Reference Citation Analysis]
34 Balta C, Herman H, Boldura OM, Gasca I, Rosu M, Ardelean A, Hermenean A. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway. Chemico-Biological Interactions 2015;240:94-101. [DOI: 10.1016/j.cbi.2015.08.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
35 Garbelli R, de Bock F, Medici V, Rousset MC, Villani F, Boussadia B, Arango-Lievano M, Jeanneteau F, Daneman R, Bartolomei F, Marchi N. PDGFRβ(+) cells in human and experimental neuro-vascular dysplasia and seizures. Neuroscience 2015;306:18-27. [PMID: 26283024 DOI: 10.1016/j.neuroscience.2015.07.090] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
36 Kikuchi A, Monga SP. PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer. Gene Expr 2015;16:109-27. [PMID: 25700367 DOI: 10.3727/105221615X14181438356210] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
37 Gao Q, Li Y, Li M. The potential role of IL-33/ST2 signaling in fibrotic diseases. J Leukoc Biol 2015;98:15-22. [PMID: 25881899 DOI: 10.1189/jlb.3RU0115-012R] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
38 Ramani K, Donoyan S, Tomasi ML, Park S. Role of methionine adenosyltransferase α2 and β phosphorylation and stabilization in human hepatic stellate cell trans-differentiation. J Cell Physiol 2015;230:1075-85. [PMID: 25294683 DOI: 10.1002/jcp.24839] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
39 Borkham-Kamphorst E, Meurer SK, Van de Leur E, Haas U, Tihaa L, Weiskirchen R. PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β. Cell Signal 2015;27:1305-14. [PMID: 25819339 DOI: 10.1016/j.cellsig.2015.03.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
40 Tag CG, Sauer-Lehnen S, Weiskirchen S, Borkham-Kamphorst E, Tolba RH, Tacke F, Weiskirchen R. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J Vis Exp. 2015;96:52438. [PMID: 25741630 DOI: 10.3791/52438] [Cited by in Crossref: 80] [Cited by in F6Publishing: 123] [Article Influence: 11.4] [Reference Citation Analysis]
41 Nair DG, Weiskirchen R, Al-Musharafi SK. The use of marine-derived bioactive compounds as potential hepatoprotective agents. Acta Pharmacol Sin 2015;36:158-70. [PMID: 25500871 DOI: 10.1038/aps.2014.114] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
42 Borkham-Kamphorst E, Alexi P, Tihaa L, Haas U, Weiskirchen R. Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities. Biochem Biophys Res Commun 2015;457:307-13. [PMID: 25576870 DOI: 10.1016/j.bbrc.2014.12.106] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
43 Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7312-7324 [PMID: 24966602 DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 270] [Cited by in F6Publishing: 220] [Article Influence: 33.8] [Reference Citation Analysis]
44 Tsai TH, Shih SC, Ho TC, Ma HI, Liu MY, Chen SL, Tsao YP. Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor. PLoS One. 2014;9:e95443. [PMID: 24763086 DOI: 10.1371/journal.pone.0095443] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
45 Chen MF, Huang CC, Liu PS, Chen CH, Shiu LY. Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells. J Med Food 2013;16:793-800. [PMID: 24044489 DOI: 10.1089/jmf.2013.2762] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
46 Borkham-Kamphorst E, Schaffrath C, Van de Leur E, Haas U, Tihaa L, Meurer SK, Nevzorova YA, Liedtke C, Weiskirchen R. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling. Biochim Biophys Acta 2014;1843:902-14. [PMID: 24487063 DOI: 10.1016/j.bbamcr.2014.01.023] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
47 Peng Y, Yang H, Wang N, Ouyang Y, Yi Y, Liao L, Shen H, Hu G, Wang Z, Tao L. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2014;306:G253-63. [PMID: 24337009 DOI: 10.1152/ajpgi.00471.2012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
48 Westra IM, Oosterhuis D, Groothuis GM, Olinga P. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol Appl Pharmacol 2014;274:328-38. [PMID: 24321339 DOI: 10.1016/j.taap.2013.11.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
49 Wang Q, Du H, Li M, Li Y, Liu S, Gao P, Zhang X, Cheng J. MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet. Evid Based Complement Alternat Med 2013;2013:368103. [PMID: 23762126 DOI: 10.1155/2013/368103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
50 Huang W, Zhu X. Correlation between PDGFs and their receptor and liver fibrosis. Shijie Huaren Xiaohua Zazhi 2013; 21(9): 773-778 [DOI: 10.11569/wcjd.v21.i9.773] [Reference Citation Analysis]
51 Peng Y, Yang H, Zhu T, Zhao M, Deng Y, Liu B, Shen H, Hu G, Wang Z, Tao L. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. Eur J Clin Invest 2013;43:358-68. [DOI: 10.1111/eci.12053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
52 Woodhoo A, Iruarrizaga-Lejarreta M, Beraza N, García-Rodríguez JL, Embade N, Fernández-Ramos D, Martínez-López N, Gutiérrez-De Juan V, Arteta B, Caballeria J, Lu SC, Mato JM, Varela-Rey M, Martínez-Chantar ML. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology 2012;56:1870-82. [PMID: 22576182 DOI: 10.1002/hep.25828] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
53 Nevzorova YA, Bangen JM, Hu W, Haas U, Weiskirchen R, Gassler N, Huss S, Tacke F, Sicinski P, Trautwein C, Liedtke C. Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice. Hepatology 2012;56:1140-9. [PMID: 22454377 DOI: 10.1002/hep.25736] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
54 Chen Y, Agrawal P, Brown RV, Hatzakis E, Hurley L, Yang D. The major G-quadruplex formed in the human platelet-derived growth factor receptor β promoter adopts a novel broken-strand structure in K+ solution. J Am Chem Soc 2012;134:13220-3. [PMID: 22866911 DOI: 10.1021/ja305764d] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
55 Reichenbach V, Fernández-Varo G, Casals G, Oró D, Ros J, Melgar-Lesmes P, Weiskirchen R, Morales-Ruiz M, Jiménez W. Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats. J Hepatol 2012;57:967-73. [PMID: 22820479 DOI: 10.1016/j.jhep.2012.07.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
56 Hao ZM, Fan XB, Li S, Lv YF, Su HQ, Jiang HP, Li HH. Vaccination with platelet-derived growth factor B kinoids inhibits CCl4-induced hepatic fibrosis in mice. J Pharmacol Exp Ther. 2012;342:835-842. [PMID: 22711911 DOI: 10.1124/jpet.112.194357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
57 Leask A. Getting out of a sticky situation: targeting the myofibroblast in scleroderma. Open Rheumatol J 2012;6:163-9. [PMID: 22802915 DOI: 10.2174/1874312901206010163] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
58 Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver Int 2012;32:1342-53. [PMID: 22698069 DOI: 10.1111/j.1478-3231.2012.02837.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
59 Xiao X, Gang Y, Gu Y, Zhao L, Chu J, Zhou J, Cai X, Zhang H, Xu L, Nie Y. Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation. Dig Dis Sci. 2012;57:2883-2891. [PMID: 22661273 DOI: 10.1007/s10620-012-2248-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
60 Thoen LF, Guimarães EL, Dollé L, Mannaerts I, Najimi M, Sokal E, van Grunsven LA. A role for autophagy during hepatic stellate cell activation. Journal of Hepatology 2011;55:1353-60. [DOI: 10.1016/j.jhep.2011.07.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 241] [Article Influence: 19.3] [Reference Citation Analysis]
61 Chen W, Liang L, Ma T, Li J, Xu G, Zhang Y, Bai X, Liang T. Role of hepatic stellate cells on graft injury after small-for-size liver transplantation: Role of HSC on graft injury after SLT. Journal of Gastroenterology and Hepatology 2011;26:1659-68. [DOI: 10.1111/j.1440-1746.2011.06781.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
62 Reyes-Gordillo K, Shah R, Popratiloff A, Fu S, Hindle A, Brody F, Rojkind M. Thymosin-β4 (Tβ4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells. Am J Pathol 2011;178:2100-8. [PMID: 21514425 DOI: 10.1016/j.ajpath.2011.01.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011;412:74-79. [PMID: 21798245 DOI: 10.1016/j.bbrc.2011.07.041] [Cited by in Crossref: 119] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
64 Borkham-Kamphorst E, van Roeyen CR, Van de Leur E, Floege J, Weiskirchen R. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. J Cell Commun Signal 2012;6:11-25. [PMID: 21748432 DOI: 10.1007/s12079-011-0141-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
65 Zhang Y, Guo J, Dong H, Zhao X, Zhou L, Li X, Liu J, Niu Y. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. European Journal of Pharmacology 2011;660:438-44. [DOI: 10.1016/j.ejphar.2011.04.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
66 Rowe RG, Lin Y, Shimizu-Hirota R, Hanada S, Neilson EG, Greenson JK, Weiss SJ. Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol. 2011;31:2392-2403. [PMID: 21482667 DOI: 10.1128/MCB.01218-10] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 8.1] [Reference Citation Analysis]
67 Rudić JS, Ćulafić ĐM, Mirković DS, Ješić RS, Krstić MN. Role of serotonin in development of esophageal and gastric fundal varices. World J Gastroenterol 2010; 16(48): 6135-6138 [PMID: 21182230 DOI: 10.3748/wjg.v16.i48.6135] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Meurer SK, Tihaa L, Borkham-Kamphorst E, Weiskirchen R. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal. 2011;23:683-699. [PMID: 21146604 DOI: 10.1016/j.cellsig.2010.12.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
69 Ogawa S, Ochi T, Shimada H, Inagaki K, Fujita I, Nii A, Moffat MA, Katragadda M, Violand BN, Arch RH, Masferrer JL. Anti-PDGF-B monoclonal antibody reduces liver fibrosis development. Hepatol Res. 2010;40:1128-1141. [PMID: 20880061 DOI: 10.1111/j.1872-034x.2010.00718.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
70 Atta HM. Gene therapy for liver regeneration: Experimental studies and prospects for clinical trials. World J Gastroenterol 2010; 16(32): 4019-4030 [PMID: 20731015 DOI: 10.3748/wjg.v16.i32.4019] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
71 Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 2010;53:132-144. [PMID: 20447716 DOI: 10.1016/j.jhep.2010.02.027] [Cited by in Crossref: 159] [Cited by in F6Publishing: 167] [Article Influence: 13.3] [Reference Citation Analysis]
72 Tacke F, Weiskirchen R. [Liver fibrosis - pathogenesis and novel therapeutic approaches]. Internist (Berl). 2010;51:21-29. [PMID: 20012930 DOI: 10.1007/s00108-009-2419-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
73 Guo-qiu W, Nai-feng L, Xiao-bo F, Linxian L, Chen Z, Lixia G, Zhao L. The Level of Connective Tissue Growth Factor in Sera of Patients with Hepatitis B Virus Strongly Correlates with Stage of Hepatic Fibrosis. Viral Immunology 2010;23:71-8. [DOI: 10.1089/vim.2009.0067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
74 Sumiyoshi M, Sakanaka M, Kimura Y. Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice. Br J Nutr 2010;103:378-85. [DOI: 10.1017/s0007114509991772] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
75 Ma J, Li F, Liu L, Cui D, Wu X, Jiang X, Jiang H. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int. 2009;29:567-574. [PMID: 19323783 DOI: 10.1111/j.1478-3231.2009.01981.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
76 Roderfeld M, Weiskirchen R, Atanasova S, Gressner AM, Preissner KT, Roeb E, Kanse SM. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells. Liver International 2009;29:686-91. [DOI: 10.1111/j.1478-3231.2008.01897.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
77 Cheung KF, Ye DW, Yang ZF, Lu L, Liu CH, Wang XL, Poon RT, Tong Y, Liu P, Chen YC. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol. 2009;124:142-150. [PMID: 19501992 DOI: 10.1016/j.jep.2009.03.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
78 Moreno M, Bataller R. Cytokines and renin-angiotensin system signaling in hepatic fibrosis. Clin Liver Dis. 2008;12:825-852, ix. [PMID: 18984469 DOI: 10.1016/j.cld.2008.07.013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
79 Wasmuth HE, Tag CG, Van de Leur E, Hellerbrand C, Mueller T, Berg T, Puhl G, Neuhaus P, Samuel D, Trautwein C, Kanse SM, Weiskirchen R. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB. Hepatology 2009;49:775-80. [PMID: 19105210 DOI: 10.1002/hep.22707] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
80 Hou YG, Zhang YY, Jia J, Hu Y, Wu S, Fang BW. Effects of peroxisome proliferator-activated receptor γ on the maintenance of quiescent phenotype of hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2008; 16(33): 3765-3768 [DOI: 10.11569/wcjd.v16.i33.3765] [Reference Citation Analysis]
81 Toki T, Kanezaki R, Adachi S, Fujino H, Xu G, Sato T, Suzuki K, Tauchi H, Endo M, Ito E. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia. Leukemia 2009;23:95-103. [PMID: 18830255 DOI: 10.1038/leu.2008.267] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
82 Das SK, Vasudevan DM. Genesis of hepatic fibrosis and its biochemical markers. Scand J Clin Lab Invest. 2008;68:260-269. [PMID: 18609066 DOI: 10.1080/00365510701668516] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
83 Borkham-Kamphorst E, Kovalenko E, van Roeyen CR, Gassler N, Bomble M, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest. 2008;88:1090-1100. [PMID: 18663351 DOI: 10.1038/labinvest.2008.71] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 5.8] [Reference Citation Analysis]
84 Okayama T, Kikuchi S, Ochiai T, Ikoma H, Kubota T, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Sonoyama T, Kokuba Y, Doi Y, Tsukita S, Bissell DM, Otsuji E. Attenuated response to liver injury in moesin-deficient mice: impaired stellate cell migration and decreased fibrosis. Biochim Biophys Acta 2008;1782:542-8. [PMID: 18606220 DOI: 10.1016/j.bbadis.2008.06.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
85 Chen SW, Chen YX, Zhang XR, Qian H, Chen WZ, Xie WF. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther. 2008;15:1424-1435. [PMID: 18509379 DOI: 10.1038/gt.2008.93] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
86 Chen SW, Zhang XR, Wang CZ, Chen WZ, Xie WF, Chen YX. RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats. Liver Int. 2008;28:1446-1457. [PMID: 18466260 DOI: 10.1111/j.1478-3231.2008.01759.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
87 Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J. 2008;411:1-18. [PMID: 18333835 DOI: 10.1042/bj20071570] [Cited by in Crossref: 217] [Cited by in F6Publishing: 219] [Article Influence: 15.5] [Reference Citation Analysis]
88 Lin J, Chen A. Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab Invest. 2008;88:529-540. [PMID: 18332871 DOI: 10.1038/labinvest.2008.20] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
89 Gressner OA, Lahme B, Siluschek M, Rehbein K, Herrmann J, Weiskirchen R, Gressner AM. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J Cell Mol Med 2008;12:2717-30. [PMID: 18266973 DOI: 10.1111/j.1582-4934.2008.00260.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
90 Chen S, Bu G, Takei Y, Sakamoto K, Ikematsu S, Muramatsu T, Kadomatsu K. Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J Cell Sci 2007;120:4009-15. [PMID: 17971413 DOI: 10.1242/jcs.013946] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
91 Zvibel I, Bar-Zohar D, Kloog Y, Oren R, Reif S. The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells. Dig Dis Sci 2008;53:1048-53. [PMID: 17934818 DOI: 10.1007/s10620-007-9984-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
92 Li Z, Dranoff JA, Chan EP, Uemura M, Sévigny J, Wells RG. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 2007;46:1246-56. [PMID: 17625791 DOI: 10.1002/hep.21792] [Cited by in Crossref: 252] [Cited by in F6Publishing: 236] [Article Influence: 16.8] [Reference Citation Analysis]
93 Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res. 2008;25:249-258. [PMID: 17577645 DOI: 10.1007/s11095-007-9311-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
94 Du SL, Pan H, Lu WY, Wang J, Wu J, Wang JY. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats. J Pharmacol Exp Ther. 2007;322:560-568. [PMID: 17510318 DOI: 10.1124/jpet.107.122481] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
95 Shen YM, Zhu X. Signal transduction and activation of hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2007; 15(8): 873-878 [DOI: 10.11569/wcjd.v15.i8.873] [Reference Citation Analysis]
96 Gonzalo T, Beljaars L, van de Bovenkamp M, Temming K, van Loenen AM, Reker-Smit C, Meijer DK, Lacombe M, Opdam F, Kéri G. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells. J Pharmacol Exp Ther. 2007;321:856-865. [PMID: 17369283 DOI: 10.1124/jpet.106.114496] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
97 Abe H, Uto H, Takami Y, Takahama Y, Hasuike S, Kodama M, Nagata K, Moriuchi A, Numata M, Ido A. Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats. Biochem Biophys Res Commun. 2007;356:610-615. [PMID: 17382907 DOI: 10.1016/j.bbrc.2007.03.035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
98 Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, Sicklick JK, Huang J, Choi S, Suzuki A, Diehl AM. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest. 2007;87:499-514. [PMID: 17334411 DOI: 10.1038/labinvest.3700537] [Cited by in Crossref: 123] [Cited by in F6Publishing: 124] [Article Influence: 8.2] [Reference Citation Analysis]
99 Kinoshita K, Iimuro Y, Fujimoto J, Inagaki Y, Namikawa K, Kiyama H, Nakajima Y, Otogawa K, Kawada N, Friedman SL, Ikeda K. Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis. Gut 2007;56:396-404. [PMID: 16956920 DOI: 10.1136/gut.2005.085704] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
100 Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol. 2007;46:1064-1074. [PMID: 17397961 DOI: 10.1016/j.jhep.2007.01.029] [Cited by in Crossref: 125] [Cited by in F6Publishing: 127] [Article Influence: 8.3] [Reference Citation Analysis]
101 Patsenker E, Popov Y, Wiesner M, Goodman SL, Schuppan D. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J Hepatol 2007;46:878-87. [PMID: 17258347 DOI: 10.1016/j.jhep.2006.11.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
102 Lechuga CG, Hernández-nazara ZH, Hernández E, Bustamante M, Desierto G, Cotty A, Dharker N, Choe M, Rojkind M. PI3K is involved in PDGF-β receptor upregulation post-PDGF-BB treatment in mouse HSC. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006;291:G1051-61. [DOI: 10.1152/ajpgi.00058.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
103 Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 2006;169:861-76. [PMID: 16936262 DOI: 10.2353/ajpath.2006.050767] [Cited by in Crossref: 116] [Cited by in F6Publishing: 120] [Article Influence: 7.3] [Reference Citation Analysis]
104 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1111/j.1582-4934.2006.tb00292.x] [Cited by in Crossref: 512] [Cited by in F6Publishing: 548] [Article Influence: 32.0] [Reference Citation Analysis]
105 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1634/stemcells.2007-0252"> [DOI: 10.1111/j.1582-4934.2006.tb00292.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1111/J.1528-4934.2006.th00292.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol. 2006;45:419-428. [PMID: 16842882 DOI: 10.1016/j.jhep.2006.04.010] [Cited by in Crossref: 160] [Cited by in F6Publishing: 160] [Article Influence: 10.0] [Reference Citation Analysis]
108 Neef M, Ledermann M, Saegesser H, Schneider V, Widmer N, Decosterd LA, Rochat B, Reichen J. Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of Hepatology 2006;44:167-75. [DOI: 10.1016/j.jhep.2005.06.015] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
109 Bandapalli OR, Geheeb M, Kobelt D, Kuehnle K, Elezkurtaj S, Herrmann J, Gressner AM, Weiskirchen R, Beule D, Blüthgen N, Herzel H, Franke C, Brand K. Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 2006;118:74-89. [PMID: 16080196 DOI: 10.1002/ijc.21307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
110 Eckel F, von Delius S, Mayr M, Dobritz M, Fend F, Hosius C, Schleyer E, Schulte-Frohlinde E, Schmid RM, Lersch C. Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology. 2005;69:363-371. [PMID: 16319507 DOI: 10.1159/000089990] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
111 Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33-60. [PMID: 16139830 DOI: 10.1016/j.cca.2005.06.014] [Cited by in Crossref: 223] [Cited by in F6Publishing: 244] [Article Influence: 13.1] [Reference Citation Analysis]
112 Jankov RP, Kantores C, Belcastro R, Yi S, Ridsdale RA, Post M, Tanswell AK. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2005;288:L1162-70. [PMID: 15722379 DOI: 10.1152/ajplung.00180.2004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
113 Borkham-Kamphorst E, Stoll D, Gressner AM, Weiskirchen R. Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis. Biochem Biophys Res Commun. 2004;321:413-423. [PMID: 15358192 DOI: 10.1016/j.bbrc.2004.06.153] [Cited by in Crossref: 62] [Cited by in F6Publishing: 72] [Article Influence: 3.4] [Reference Citation Analysis]